Right Decisions
TAM (Treatments and Medicines) NHS Highland
FORMULARIES
HIGHLAND FORMULARY
RESPIRATORY SYSTEM
Antihistamines, hyposensitisation and allergic emergencies
Back
Allergic and respiratory emergencies
Other respiratory emergencies (Formulary)

Update your RDS mobile app to v4.7.1 to download toolkits even when website is down.

We are pleased to advise that deep linking capability, enabling users to directly download individual mobile toolkits, has now been released on the RDS mobile app. You will see that each toolkit has a small QR code icon in the header area beside the search icon – see screenshot below. Clicking on this icon will open up a window with a full-size QR code and the alternative of a short URL for sharing with users. Instructions are provided.

You may need to actively update to the latest release - RDS app version 4.7.1 - to see this improvement.

Updating to this latest version of the RDS app is also strongly recommended to get the full benefits of the new resilience arrangements – specifically, that if the RDS website should fail, you will still be able to download new mobile app toolkits. To check your current RDS version, click on the three dots bottom right of the RDS app screen. This takes you to a “More” page where you will see the version number. To install latest updates:

On iPhones – go to the Apple store, click on your profile icon top right, scroll down to see the apps waiting to be updated and update the RDS app.

On Android phones – these can vary, but try going to the Google Play store, click on your profile icon top right, click on “Manage apps and device”, select and update the RDS app.

Please get in touch with ann.wales3@nhs.scot with any questions.

Other respiratory emergencies (Formulary)

TAM (Treatments and Medicines) NHS Highland

NHS Highland

ALTEPLASE

Important: Therapy notes

Refer to guidance in respiratory handbook on Ward 7a, Raigmore Hospital.
For use in the management of hyper-acute stroke refer to Stable angina, acute coronary syndromes and fibrinolysis.

Important: Formulation and dosage details

Formulation:

Injection 10mg (5·8 million units/vial), 50mg (29 million units/vial) (s)

Dosage:

By intravenous injection, for the treatment of pulmonary embolism following specialist advice: 10mg over 1 to 2 minutes, followed by intravenous infusion of 90mg over 2 hours; max 1·5mg/kg in patients less than 65kg.

By intrapleural injection, for the treatment of empyema off-label: 10mg every 12 hours for three days (followed by 5mg intrapleural dornase alfa (Mucolytics) off-label one hour after each alteplase injection and subsequent free drainage).